A
Amelia Hall
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
May 26, 2026
Mindscapes: The Science of Meaning
0:32
0:47
0:59
1:14
1:44
5:16

Matt SaintsingHOST
Can you please briefly talk about what drew you into working with, uh, psychedelic, uh, in the field of psychedelic science, um, uh, and study of how you make meaning from those experiences?

Amelia HallGUEST
I mean, it's a long story, but I've been working at, um, this university, Naropa University, for 11 years, and we are what-- we, we call ourselves a Buddhist-inspired university.

Amelia HallGUEST
We're not necessarily a conventional faith-based institution, but we take a lot of inspiration and teachings from various Buddhist traditions, and that's my academic background.

Amelia HallGUEST
And so my background in Buddhist studies, um, particularly, and, and, and all, and I would say all kinds of different spiritual tradit- traditions and contemplative practices, I think has given me a sort of lens for what has been emerging in the last few years around psychedelic-assisted therapy, and that we ha- we, we've been exploring what that looks like at our university.

Amelia HallGUEST
We're located in Colorado, so it's one of the few places in the country right now that, um, has l- legal ... has, I wanna say in, in brackets, legalized the use of psychedelics in certain ways for, um, for therapy.

Matt SaintsingHOST
But I, I'm cur- I'm curious, how do you differentiate meaning from the clinical outcomes? A lot of attention is on, like, the s- you know, how do people feel when their symptom changes, right? There's less about, you know, what, what are you taking away from this experience? I'm kinda curious how you kinda toggle back between those two, um, worlds.